Literature DB >> 26821979

Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain.

J Borg1,2, S Cervenka1, R Kuja-Halkola2, G J Matheson1, E G Jönsson1,3, P Lichtenstein2, S Henningsson4, T Ichimiya1,5, H Larsson2, P Stenkrona1, C Halldin1, L Farde1,6.   

Abstract

The dopamine (DA) and serotonin (5-HT) neurotransmission systems are of fundamental importance for normal brain function and serve as targets for treatment of major neuropsychiatric disorders. Despite central interest for these neurotransmission systems in psychiatry research, little is known about the regulation of receptor and transporter density levels. This lack of knowledge obscures interpretation of differences in protein availability reported in psychiatric patients. In this study, we used positron emission tomography (PET) in a twin design to estimate the relative contribution of genetic and environmental factors, respectively, on dopaminergic and serotonergic markers in the living human brain. Eleven monozygotic and 10 dizygotic healthy male twin pairs were examined with PET and [(11)C]raclopride binding to the D2- and D3-dopamine receptor and [(11)C]WAY100635 binding to the serotonin 5-HT1A receptor. Heritability, shared environmental effects and individual-specific non-shared effects were estimated for regional D2/3 and 5-HT1A receptor availability in projection areas. We found a major contribution of genetic factors (0.67) on individual variability in striatal D2/3 receptor binding and a major contribution of environmental factors (pairwise shared and unique individual; 0.70-0.75) on neocortical 5-HT1A receptor binding. Our findings indicate that individual variation in neuroreceptor availability in the adult brain is the end point of a nature-nurture interplay, and call for increased efforts to identify not only the genetic but also the environmental factors that influence neurotransmission in health and disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26821979     DOI: 10.1038/mp.2015.147

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  70 in total

1.  Striatal dopamine (D2) receptor availability predicts socially desirable responding.

Authors:  Suzanne J Reeves; Mitul A Mehta; Andrew J Montgomery; Dimitri Amiras; Alice Egerton; Robert J Howard; Paul M Grasby
Journal:  Neuroimage       Date:  2006-12-26       Impact factor: 6.556

2.  Brain dopamine d1 receptors in twins discordant for schizophrenia.

Authors:  Jussi Hirvonen; Theo G M van Erp; Jukka Huttunen; Sargo Aalto; Kjell Någren; Matti Huttunen; Jouko Lönnqvist; Jaakko Kaprio; Tyrone D Cannon; Jarmo Hietala
Journal:  Am J Psychiatry       Date:  2006-10       Impact factor: 18.112

3.  Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; David Alexoff; Jean Logan; Millard Jayne; Christopher Wong; Dardo Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

4.  Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

Authors:  E G Jönsson; M M Nöthen; F Grünhage; L Farde; Y Nakashima; P Propping; G C Sedvall
Journal:  Mol Psychiatry       Date:  1999-05       Impact factor: 15.992

5.  Age-related cognitive deficits mediated by changes in the striatal dopamine system.

Authors:  L Bäckman; N Ginovart; R A Dixon; T B Wahlin; A Wahlin; C Halldin; L Farde
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

6.  Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.

Authors:  O Mawlawi; D Martinez; M Slifstein; A Broft; R Chatterjee; D R Hwang; Y Huang; N Simpson; K Ngo; R Van Heertum; M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2001-09       Impact factor: 6.200

7.  Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations.

Authors:  Ramin V Parsey; R Todd Ogden; Jeffrey M Miller; Adrienne Tin; Natalie Hesselgrave; Ellen Goldstein; Arthur Mikhno; Matthew Milak; Francesca Zanderigo; Gregory M Sullivan; Maria A Oquendo; J John Mann
Journal:  Biol Psychiatry       Date:  2010-05-23       Impact factor: 13.382

8.  Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability.

Authors:  Simon Cervenka; J Petter Gustavsson; Christer Halldin; Lars Farde
Journal:  Neuroimage       Date:  2009-12-11       Impact factor: 6.556

9.  Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers.

Authors:  Mitul A Mehta; Facundo F Manes; Gianna Magnolfi; Barbara J Sahakian; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2004-04-28       Impact factor: 4.530

10.  Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635.

Authors:  Gregory M Sullivan; R Todd Ogden; Yung-Yu Huang; Maria A Oquendo; J John Mann; Ramin V Parsey
Journal:  Depress Anxiety       Date:  2013-02-13       Impact factor: 6.505

View more
  5 in total

1.  DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum.

Authors:  Mikaeel Valli; Sang Soo Cho; Mario Masellis; Robert Chen; Pablo Rusjan; Jinhee Kim; Yuko Koshimori; Alexander Mihaescu; Antonio P Strafella
Journal:  Mol Neurobiol       Date:  2019-03-08       Impact factor: 5.590

2.  Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.

Authors:  Sarah A Eisenstein; Ryan Bogdan; Latisha Love-Gregory; Nadia S Corral-Frías; Jonathan M Koller; Kevin J Black; Stephen M Moerlein; Joel S Perlmutter; Deanna M Barch; Tamara Hershey
Journal:  Synapse       Date:  2016-06-17       Impact factor: 2.562

Review 3.  Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders.

Authors:  Lars Farde; Pontus Plavén-Sigray; Jacqueline Borg; Simon Cervenka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-04-19       Impact factor: 6.237

4.  Serotonin 5-HT1A receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing.

Authors:  Gina Griffioen; Granville J Matheson; Simon Cervenka; Lars Farde; Jacqueline Borg
Journal:  PeerJ       Date:  2018-11-16       Impact factor: 2.984

5.  Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men.

Authors:  Fernando Caravaggio; Pontus Plavén-Sigray; Granville James Matheson; Eric Plitman; M Mallar Chakravarty; Jacqueline Borg; Ariel Graff-Guerrero; Simon Cervenka
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.